SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: E who wrote (2731)7/21/1999 2:28:00 PM
From: Jacques Chitte  Read Replies (2) of 4140
 
I'm no MD, but I have some passing acquaintance with clinical protocols.

Imho there are two big questions here.
1) The VISX procedure is surgery with a laser, i.e. invasive. By the sound of it - it trades contrast for acuity. This is to be expected if tissue is removed.
The SNRS procedure is non-surgical (do I have this right, MDs?) - tissue is not removed, nor is the continuity of eye tissue disturbed. In an optical system, flare and hazing is the result if discontinuities - if the overall curvature is correct, as I'd expect it to be after a spell of VISX.

2) There was no baseline to tell if the VISX procedure worsened or just "didn't improve" night vision. For me personally this is very disheartening. One of my hobbies is stargazing, and my right eye has gone myopic. If the Pleiades (which once looked glorious to my naked eyes but are now a patch of faint fuzz) are still a blur after VISX, I would consider it money thrown away. Maybe tomorrow we will get soem more info on whether the SNRS procedure keeps night vision parameters (sensitivity to low light and low contrast) intact.

To summarize, both are REAL concerns, but the jury is out on either. We need more data.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext